Newsfeeds - Spark Newswire

1 minute read

Today, 3:31 PM

Digital health service offers Lucira lab-quality at-home test users a telehealth visit at no additional cost, enabling Test-to-Treatment within hours for only $29, excluding prescription costs Lucira

LHDX

6 minute read

Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:31 PM

Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.

ACMR

3 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 3:31 PM

On Tuesday, 34 companies set new 52-week lows.

CHRA

1 minute read

UPDATE: Lucira Health Q3 EPS $(0.38), Inline, Sales $34.39M Beat $32.79M Estimate

By Benzinga Newsdesk

Today, 3:31 PM

Lucira Health (NASDAQ:LHDX) reported quarterly losses of $(0.38) per share which met the analyst consensus estimate. This is a 19.15 percent increase over losses of $(0.47) per share from the same period last year. The

LHDX

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

Today, 3:31 PM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC